Hydrochloric Acid

Hydrochloric Acid

SCHEMBL142028

CCCCCCCCC=CCCCCCCCC1N(CCO)CCN1CCO.Cl

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.37
TOP1 known ✓ P11387 1/20 0.37
CYP19A1 known ✓ P11511 1/20 0.37
PTGS1 known ✓ P23219 1/20 0.37
SLC6A2 known ✓ P23975 1/20 0.37
FLT3 known ✓ P36888 1/20 0.37
PPARG known ✓ P37231 1/20 0.37
KCNH2 known ✓ Q12809 1/20 0.37
FAAH O00519 3/20 0.37
TRPV1 Q8NER1 1/20 0.37
TERT O14746 3/20 0.37
MAPT P10636 2/20 0.37
BLM P54132 2/20 0.37
HSD17B10 Q99714 2/20 0.37
FABP4 P15090 2/20 0.37
GMNN O75496 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL142026 1.00 FAAH (0.37) FAAHTRPV1TERTMAPTBLM
SCHEMBL141304 0.98 FAAH (0.38) FAAHTRPV1TERTMAPTBLM
SCHEMBL141306 0.98 FAAH (0.38) FAAHTRPV1TERTMAPTBLM
SCHEMBL31085540 0.88 MEN1 (0.40) MAPTKMT2A
Hydrochloric Acid SCHEMBL29396916 0.85 MGLL (0.50) TRPV1MAPT
Hydrochloric Acid SCHEMBL1047267 0.85 MGLL (0.50) TRPV1MAPT
Hydrochloric Acid SCHEMBL28736736 0.84 MGLL (0.49) TRPV1MAPT
SCHEMBL441411 0.83 MGLL (0.51) TRPV1MAPT
SCHEMBL28968652 0.83 MGLL (0.51) TRPV1MAPT
SCHEMBL30180550 0.83 MGLL (0.51) TRPV1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2807278-B1 FAT-LIQUORING STAHL INT B V (NL) 2021-12-01 EP disclosed
EP-2633088-B1 NON METAL TANNING STAHL INT B V (NL) 2018-09-12 EP disclosed
EP-2633086-B1 NON-METAL TANNING PROCESS STAHL INT B V (NL) 2017-08-16 EP disclosed
EP-2633089-B1 NON METAL TANNING STAHL INT B V (NL) 2017-03-15 EP disclosed
EP-2638181-B1 NON METAL TANNING STAHL INT B V (NL) 2017-02-22 EP disclosed
US-9447477-B2 Fat-liquoring STAHL INTERNATIONAL B.V. (NL) 2016-09-20 US disclosed
US-20140366280-A1 FAT-LIQUORING STAHL INTERNATIONAL B.V. (NL) 2014-12-18 US disclosed
EP-2807278-A1 FAT-LIQUORING Stahl International B.V. (NL) 2014-12-03 EP disclosed
EP-2638179-B1 NON METAL TANNING STAHL INT BV (NL) 2014-11-26 EP disclosed
EP-2638180-B1 NON METAL TANNING STAHL INT BV (NL) 2014-11-26 EP disclosed
WO-2012062413-A1 NON METAL TANNING CLARIANT INTERNATIONAL LTD (CH) 2012-05-18 WO disclosed
WO-2012062412-A1 NON METAL TANNING CLARIANT INTERNATIONAL LTD (CH) 2012-05-18 WO disclosed
WO-2012062411-A1 NON METAL TANNING CLARIANT INTERNATIONAL LTD (CH) 2012-05-18 WO disclosed
WO-2012055480-A1 NON METAL TANNING CLARIANT INTERNATIONAL LTD (CH) 2012-05-03 WO disclosed
WO-2012055481-A1 NON METAL TANNING CLARIANT INTERNATIONAL LTD (CH) 2012-05-03 WO disclosed
WO-2012055482-A1 NON-METAL TANNING PROCESS CLARIANT INTERNATIONAL LTD (CH) 2012-05-03 WO disclosed
WO-2012055483-A1 NON-METAL TANNING PROCESS CLARIANT INTERNATIONAL LTD (CH) 2012-05-03 WO disclosed
EP-2430197-A1 TANNING PROCESS AND TANNING COMPOSITION Clariant Finance (BVI) Limited (VG) 2012-03-21 EP disclosed
US-20120058357-A1 Tanning Process and Tanning Composition CLARIANT FINANCE (BVI) LIMITED (VG) 2012-03-08 US disclosed
WO-2010130311-A1 TANNING PROCESS AND TANNING COMPOSITION CLARIANT INTERNATIONAL LTD (CH) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140366280-A1 FAT-LIQUORING FABP4, PLOD3, AGXT CHRM1 3633/4885TOP1 3811/4885CYP19A1 328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.